Vaxil Bio Ltd. (VXL.V)
0.13
0.00 (0.00%)
CAD |
TSXV |
Oct 23, 16:00
Vaxil Bio Max Drawdown (5Y) : 99.63% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.63% |
| August 31, 2026 | 99.63% |
| July 31, 2026 | 99.63% |
| June 30, 2026 | 99.63% |
| May 31, 2026 | 99.63% |
| April 30, 2026 | 99.63% |
| March 31, 2026 | 99.63% |
| February 28, 2026 | 99.63% |
| January 31, 2026 | 99.63% |
| December 31, 2025 | 99.63% |
| November 30, 2025 | 99.60% |
| October 31, 2025 | 99.54% |
| September 30, 2025 | 99.54% |
| August 31, 2025 | 99.54% |
| July 31, 2025 | 99.43% |
| June 30, 2025 | 99.43% |
| May 31, 2025 | 99.41% |
| April 30, 2025 | 98.57% |
| March 31, 2025 | 98.57% |
| February 28, 2025 | 98.57% |
| January 31, 2025 | 98.57% |
| December 31, 2024 | 98.57% |
| November 30, 2024 | 98.57% |
| October 31, 2024 | 98.57% |
| September 30, 2024 | 98.57% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.57% |
| July 31, 2024 | 98.57% |
| June 30, 2024 | 98.57% |
| May 31, 2024 | 98.57% |
| April 30, 2024 | 98.57% |
| March 31, 2024 | 98.57% |
| February 29, 2024 | 98.57% |
| January 31, 2024 | 98.57% |
| December 31, 2023 | 98.57% |
| November 30, 2023 | 98.57% |
| October 31, 2023 | 98.57% |
| September 30, 2023 | 98.57% |
| August 31, 2023 | 98.57% |
| July 31, 2023 | 97.86% |
| June 30, 2023 | 97.86% |
| May 31, 2023 | 97.86% |
| April 30, 2023 | 97.86% |
| March 31, 2023 | 97.86% |
| February 28, 2023 | 97.86% |
| January 31, 2023 | 97.86% |
| December 31, 2022 | 97.86% |
| November 30, 2022 | 97.86% |
| October 31, 2022 | 96.43% |
| September 30, 2022 | 96.43% |
| August 31, 2022 | 96.43% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Kane Biotech, Inc. | 89.47% |
| Quest PharmaTech, Inc. | 94.00% |
| BriaCell Therapeutics Corp. | -- |
| Waverley Pharma, Inc. | 96.77% |
| Goldcoast Resource Corp. | 99.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -55.19 |
| Beta (5Y) | -0.2281 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 92.18% |
| Historical Sharpe Ratio (5Y) | -0.6263 |
| Historical Sortino (5Y) | -1.135 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.80% |